title: Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children.
abstract: To determine whether zinc deficiency might be involved in the failure to thrive observed in undernourished Vietnamese children, we assessed growth, incidence of infections, and circulating insulin-like growth factor I (IGF-I) concentrations in a double-blind study of zinc supplementation. Growth-retarded children (n=146) aged 4-36 mo were paired according to age, sex, commune, Z scores for weight (WAZ) and for height (HAZ), and number of siblings, and were randomly assigned to receive either 153 micromol (10 mg) Zn/d or a placebo for 5 mo. Weight, height, and episodes of infection were recorded each month and plasma IGF-I was measured 1 and 5 mo after the start of zinc supplementation. Multiple-linear-regression analysis for paired data showed that zinc supplementation increased weight (+0.5 +/- 0.1 kg; P<0.001) and height (+1.5+/-0.2 cm; P<0.001) after 5 mo compared with placebo treatment. The relative risk of infectious episodes in the zinc-treated subjects was reduced 3-fold for diarrhea (P=0.012) and 2.5-fold for respiratory infections (p=0.057). The probability of having at least two episodes of diarrhea or respiratory infection was 2.9- and 3.2-fold lower, respectively, in zinc-treated subjects between 1 and 5 mo (P=0.018), whereas they did not change in placebo-treated subjects (P-0.584). After 1 mo, IGF-I concentration (-x+/-SD) in zinc-treated subjects was 2.8+/-0.3 nmol/L compared with 1.9+/-0.2 nmol/L in placebo-treated subjects (P=0.021). After 5 mo, the values were 3.4+/-0.5 nmol/L (zinc-treated) and 2.0+/-0.3 nmol/L (placebo-treated; P=0.044). Our study suggests that zinc deficiency may limit growth in nutritionally deprived children. Because the increase in growth velocity resulting from zinc supplementation was associated with increased plasma IGF-I concentrations, we suggest that the growth-stimulating effect of zinc might be mediated through changes in circulating IGF-I.
authors.affiliation: Diabetes and Nutrition Unit, University of Louvain, Belgium.
authors.forename: N X
authors.initials: NX
authors.lastname: Ninh
authors.forename: J P
authors.initials: JP
authors.lastname: Thissen
authors.forename: L
authors.initials: L
authors.lastname: Collette
authors.forename: G
authors.initials: G
authors.lastname: Gerard
authors.forename: H H
authors.initials: HH
authors.lastname: Khoi
authors.forename: J M
authors.initials: JM
authors.lastname: Ketelslegers
mesh_terms: D000886:Anthropometry; D002675:Child, Preschool; D003141:Communicable Diseases / Q000150:complications / Q000453:epidemiology; D004311:Double-Blind Method; D005260:Female; D005527:Food, Fortified; D006128:Growth / Q000187:drug effects* / Q000502:physiology; D006130:Growth Disorders / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D006801:Humans; D015994:Incidence; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D016015:Logistic Models; D008297:Male; D012307:Risk Factors; D014744:Vietnam / Q000453:epidemiology; D015032:Zinc / Q000008:administration & dosage / Q000172:deficiency / Q000494:pharmacology*
chemical_list: D007334:Insulin-Like Growth Factor I; D015032:Zinc